- Global Biotechnology Company | CSL
CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
- Global Biotechnology Company | CSL
Our parent company, CSL, headquartered in Melbourne, Australia, employs more than 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries
- We Are CSL | CSL
Since our start in 1916, we have been driven by our promise to save lives using the latest technologies Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000 people
- Our Businesses and Products | CSL
CSL is committed to protecting public health and improving and saving the lives of patients with rare and serious diseases through the development, manufacture and reliable supply of high-quality medicines
- Global Newsroom | CSL
Recent News Releases Featuring releases from CSL, CSL Behring, CSL Seqirus and CSL Vifor
- Our Corporate Profile | Global Biotechnology Company | CSL
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology
- Global plasma collector | CSL
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with nearly 330 plasma donation centers globally, including the U S and Europe and employs nearly 16,000 employees
- Careers | CSL
CSL was established in Australia in 1916 Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases
|